+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants - Global Strategic Business Report

  • PDF Icon

    Report

  • 278 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6106896
The global market for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants was estimated at US$2.4 Billion in 2024 and is projected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market.

Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market - Key Trends & Drivers Summarized

What's Driving Advances in Staphylococcus Aureus Detection in Orthopedic Implants?

Staphylococcus aureus (S. aureus), particularly its methicillin-resistant strain (MRSA), is a major cause of periprosthetic joint infections (PJI) in orthopedic implants. These infections can lead to severe complications, including implant failure, osteomyelitis, and sepsis. Rapid, accurate detection and targeted treatment are critical for clinical outcomes. Conventional diagnosis relied on microbial culture, which is slow and often yields false negatives. Today, molecular diagnostics-like PCR, next-generation sequencing (NGS), and immunoassays-are enabling earlier and more reliable detection of S. aureus and associated biofilm-forming pathogens.

Advanced imaging modalities, such as FDG-PET and WBC-labeled SPECT/CT, are also being used to localize infections. Point-of-care biosensors and multiplexed panels capable of detecting resistance genes (e.g., mecA) are entering clinical use. These tools help orthopedic surgeons and infectious disease specialists make informed debridement and antibiotic choices more quickly.

Are Novel Therapies and Coatings Transforming Post-Implant Management?

Beyond diagnostics, innovations in antimicrobial coatings-silver nanoparticles, antibiotic-loaded cements, and iodine-activated surfaces-are being employed to prevent biofilm formation on implants. Personalized antibiotic regimens based on genetic profiling of pathogens are improving eradication rates. Long-acting antibiotic carriers (beads, spacers) provide localized drug delivery without systemic toxicity.

Theranostic approaches-where diagnosis and therapy are combined in a single implant or coating-are being explored for intraoperative applications. Immunotherapies and phage-based antibacterial therapies are under clinical development, targeting antibiotic-resistant strains with greater specificity.

Why Are Orthopedic Specialists Focusing on Early Intervention?

As the global volume of knee, hip, and spinal implants rises, infection prevention and control have become top priorities. S. aureus infections significantly increase revision rates, hospitalization duration, and costs. Surgeons are demanding tools that enable real-time pathogen identification during surgery to avoid unnecessary explantation. Hospitals are adopting comprehensive infection management protocols-including preoperative screening, intraoperative diagnostics, and post-op surveillance.

What's Powering the Growth in the Orthopedic S. Aureus Infection Market?

The growth in this market is driven by several factors related to orthopedic surgery volumes, diagnostic innovation, and resistance trends. The rise in joint replacement procedures globally is increasing risk and incidence of implant-related infections. Technological advancements in rapid molecular diagnostics and biofilm imaging tools are improving clinical detection rates. New antimicrobial materials and localized drug-delivery systems are expanding treatment options. Finally, the spread of antibiotic resistance is fueling investment in novel therapies, creating demand for precise and aggressive infection control solutions in orthopedic settings.

Scope Of Study:

The report analyzes the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Component (Diagnosis, Treatment); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Diagnosis segment, which is expected to reach US$1.7 Billion by 2030 with a CAGR of a 2.4%. The Treatment segment is also set to grow at 4.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $666.1 Million in 2024, and China, forecasted to grow at an impressive 5.9% CAGR to reach $579.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson (BD), BioMérieux SA, C2Dx, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants market report include:

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson (BD)
  • BioMérieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic (Molecular Diagnostics)
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos (Staphefekt)
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche (Roche Diagnostics)
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Post-Operative Infections Drives Demand for Advanced Diagnostic Solutions
  • Increase in Joint Replacement and Trauma Surgeries Spurs Need for S. aureus Monitoring
  • Growing Focus on Implant-Associated Infections Throws Spotlight on Early Detection Technologies
  • Development of Rapid Molecular Diagnostics Enhances Clinical Decision-Making
  • Antimicrobial Coating Innovations Strengthen Business Case for Preventative Orthopedic Implants
  • Regulatory Guidelines for Surgical Site Infections Drive Compliance-Based Adoption
  • AI and Machine Learning in Diagnostic Algorithms Accelerate Infection Identification Accuracy
  • Expansion of Outpatient Orthopedic Care Creates Demand for Point-of-Care Testing Kits
  • Rise in Antibiotic Resistance Fuels R&D in Novel Therapeutics and Diagnostic Pathways
  • Healthcare Cost Containment Strategies Encourage Early Diagnosis and Treatment
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton Dickinson (BD)
  • BioMérieux SA
  • C2Dx, Inc.
  • Cepheid
  • Hologic (Molecular Diagnostics)
  • Johnson & Johnson MedTech
  • MediWound
  • Merck KGaA
  • Micreos (Staphefekt)
  • Ortho Clinical Diagnostics
  • Pfizer Inc.
  • Roche (Roche Diagnostics)
  • Sabiad
  • Schwitz Biotech
  • Siemens Healthineers
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Wellona Pharma

Table Information